Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials

J Am Coll Cardiol. 2024 Apr 2;83(13):1222-1224. doi: 10.1016/j.jacc.2024.02.023. Epub 2024 Mar 25.

Authors

Peter A Schneider¹, Jeffrey W Olin²

Affiliations

¹ Division of Vascular and Endovascular Surgery, University of California-San Francisco, San Francisco, California, USA. Electronic address: peteraschneidermd@gmail.com.
² Mount Sinai Hospital, Icahn School of Medicine, New York, New York, USA.

PMID: 38538201
DOI: 10.1016/j.jacc.2024.02.023

No abstract available

Keywords: drug-coated balloon; drug-eluting stent; paclitaxel.

Publication types

Editorial

MeSH terms

Angioplasty, Balloon, Coronary
Cardiovascular Agents* / adverse effects
Coated Materials, Biocompatible
Coronary Artery Disease
Coronary Restenosis
Humans
Paclitaxel* / adverse effects
Prosthesis Design
Treatment Outcome

Substances

Cardiovascular Agents
Coated Materials, Biocompatible
Paclitaxel